Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16223854rdf:typepubmed:Citationlld:pubmed
pubmed-article:16223854lifeskim:mentionsumls-concept:C1522564lld:lifeskim
pubmed-article:16223854lifeskim:mentionsumls-concept:C0882849lld:lifeskim
pubmed-article:16223854lifeskim:mentionsumls-concept:C1554869lld:lifeskim
pubmed-article:16223854pubmed:issue2lld:pubmed
pubmed-article:16223854pubmed:dateCreated2006-3-2lld:pubmed
pubmed-article:16223854pubmed:abstractTextGranulocyte--colony-stimulating factor administered for autologous hematopoietic stem cell isolation from blood may favor restenosis in patients implanted after acute myocardial infarction (AMI). We therefore tested the isolation of peripheral-blood CD34+ cells without mobilization in six patients with AMI. After large-volume cytapheresis and positive CD34+ cell selection, 3.6 to 27.6 million CD34+ cells were obtained. We performed intra-coronary implantation of these cells and recorded no restenosis or arrhythmia. We used positron emission tomography (PET) to assess myocardial-labeled CD34+ cell homing, which accounted for 5.5% of injected cells 1 hour after implantation. In conclusion, large amounts of CD34+ cells, in the range reported in previous studies, can be obtained from nonmobilized peripheral blood. PET with [18F]-fluorodeoxyglucose cell labeling is an efficient imaging method for homing assessment.lld:pubmed
pubmed-article:16223854pubmed:languageenglld:pubmed
pubmed-article:16223854pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16223854pubmed:citationSubsetIMlld:pubmed
pubmed-article:16223854pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16223854pubmed:statusMEDLINElld:pubmed
pubmed-article:16223854pubmed:monthFeblld:pubmed
pubmed-article:16223854pubmed:issn1066-5099lld:pubmed
pubmed-article:16223854pubmed:authorpubmed-author:GoldmanMichel...lld:pubmed
pubmed-article:16223854pubmed:authorpubmed-author:GoldmanSergeSlld:pubmed
pubmed-article:16223854pubmed:authorpubmed-author:BlockletDidie...lld:pubmed
pubmed-article:16223854pubmed:authorpubmed-author:BerkenboomGuy...lld:pubmed
pubmed-article:16223854pubmed:authorpubmed-author:UngerPhilippe...lld:pubmed
pubmed-article:16223854pubmed:authorpubmed-author:LambermontMic...lld:pubmed
pubmed-article:16223854pubmed:authorpubmed-author:EgriseDominiq...lld:pubmed
pubmed-article:16223854pubmed:authorpubmed-author:ToungouzMiche...lld:pubmed
pubmed-article:16223854pubmed:authorpubmed-author:PreumontNicol...lld:pubmed
pubmed-article:16223854pubmed:authorpubmed-author:StoupelEricElld:pubmed
pubmed-article:16223854pubmed:authorpubmed-author:DegauteJean-P...lld:pubmed
pubmed-article:16223854pubmed:issnTypePrintlld:pubmed
pubmed-article:16223854pubmed:volume24lld:pubmed
pubmed-article:16223854pubmed:ownerNLMlld:pubmed
pubmed-article:16223854pubmed:authorsCompleteYlld:pubmed
pubmed-article:16223854pubmed:pagination333-6lld:pubmed
pubmed-article:16223854pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:16223854pubmed:meshHeadingpubmed-meshheading:16223854...lld:pubmed
pubmed-article:16223854pubmed:meshHeadingpubmed-meshheading:16223854...lld:pubmed
pubmed-article:16223854pubmed:meshHeadingpubmed-meshheading:16223854...lld:pubmed
pubmed-article:16223854pubmed:meshHeadingpubmed-meshheading:16223854...lld:pubmed
pubmed-article:16223854pubmed:meshHeadingpubmed-meshheading:16223854...lld:pubmed
pubmed-article:16223854pubmed:meshHeadingpubmed-meshheading:16223854...lld:pubmed
pubmed-article:16223854pubmed:meshHeadingpubmed-meshheading:16223854...lld:pubmed
pubmed-article:16223854pubmed:meshHeadingpubmed-meshheading:16223854...lld:pubmed
pubmed-article:16223854pubmed:meshHeadingpubmed-meshheading:16223854...lld:pubmed
pubmed-article:16223854pubmed:meshHeadingpubmed-meshheading:16223854...lld:pubmed
pubmed-article:16223854pubmed:meshHeadingpubmed-meshheading:16223854...lld:pubmed
pubmed-article:16223854pubmed:meshHeadingpubmed-meshheading:16223854...lld:pubmed
pubmed-article:16223854pubmed:meshHeadingpubmed-meshheading:16223854...lld:pubmed
pubmed-article:16223854pubmed:meshHeadingpubmed-meshheading:16223854...lld:pubmed
pubmed-article:16223854pubmed:meshHeadingpubmed-meshheading:16223854...lld:pubmed
pubmed-article:16223854pubmed:meshHeadingpubmed-meshheading:16223854...lld:pubmed
pubmed-article:16223854pubmed:meshHeadingpubmed-meshheading:16223854...lld:pubmed
pubmed-article:16223854pubmed:meshHeadingpubmed-meshheading:16223854...lld:pubmed
pubmed-article:16223854pubmed:meshHeadingpubmed-meshheading:16223854...lld:pubmed
pubmed-article:16223854pubmed:year2006lld:pubmed
pubmed-article:16223854pubmed:articleTitleMyocardial homing of nonmobilized peripheral-blood CD34+ cells after intracoronary injection.lld:pubmed
pubmed-article:16223854pubmed:affiliationDepartment of Nuclear Medicine and PET/Biomedical Cyclotron Unit, Hôpital Universitaire Erasme, Université Libre de Bruxelles, Brussels, Belgium. dblockle@ulb.ac.belld:pubmed
pubmed-article:16223854pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16223854pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:16223854pubmed:publicationTypeEvaluation Studieslld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16223854lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16223854lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16223854lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16223854lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16223854lld:pubmed